These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35850185)

  • 1. The impact of the size of acetylated cyclodextrin on the stability of amorphous metronidazole.
    Minecka A; Tarnacka M; Jurkiewicz K; Hachuła B; Wrzalik R; Bródka A; Kamiński K; Kamińska E
    Int J Pharm; 2022 Aug; 624():122025. PubMed ID: 35850185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures.
    Minecka A; Tarnacka M; Jurkiewicz K; Hachuła B; Wrzalik R; Kamiński K; Paluch M; Kamińska E
    Mol Pharm; 2021 Jan; 18(1):347-358. PubMed ID: 33355470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the Impact of Modified Saccharides on the Molecular Dynamics and Crystallization Tendencies of Model API Nifedipine.
    Kaminska E; Tarnacka M; Wlodarczyk P; Jurkiewicz K; Kolodziejczyk K; Dulski M; Haznar-Garbacz D; Hawelek L; Kaminski K; Wlodarczyk A; Paluch M
    Mol Pharm; 2015 Aug; 12(8):3007-19. PubMed ID: 26101945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
    Newman A; Zografi G
    Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.
    Schammé B; Couvrat N; Tognetti V; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Mol Pharm; 2018 Mar; 15(3):1112-1125. PubMed ID: 29328661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of low molecular weight excipient octaacetylmaltose on the liquid crystalline ordering and molecular dynamics in the supercooled liquid and glassy state of itraconazole.
    Kaminska E; Tarnacka M; Kolodziejczyk K; Dulski M; Zakowiecki D; Hawelek L; Adrjanowicz K; Zych M; Garbacz G; Kaminski K
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1094-104. PubMed ID: 25460155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state.
    Uzqueda M; Martín C; Zornoza A; Sánchez M; Martínez-Ohárriz MC; Vélaz I
    Pharm Res; 2006 May; 23(5):980-8. PubMed ID: 16715388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.